OpenNeedle Ask your own

Question explored with the scientific record

Does ivermectin inhibit influenza viral replication

Nov 9, 2026 · 3 sources used · OpenNeedle synthesis
The short version: no retrieved study tested ivermectin against influenza virus, and the one clinical record that mentions it found no antiviral effect.

The question is whether ivermectin blocks influenza replication. Nothing in this retrieval answers that. The records cover metformin's effects on flu and COVID [1], a fungal circadian clock study where ivermectin was used as a lab tool [2], and ivermectin's action on parasite vesicles [3]. None tested influenza virus.

The closest thing is a secondary analysis of the COVID-OUT trial, which reported no virological effect for ivermectin on SARS-CoV-2 viral load, while metformin cut viral load 3.6-fold [1]. That is a different virus and a different disease, so it does not settle influenza. But it is the only human antiviral readout here, and it came up empty.

RecordWhat it testedIvermectin result
COVID-OUT secondary analysis [1]SARS-CoV-2 viral loadNo virological effect
Neurospora clock study [2]Fungal nuclear importUsed as inhibitor tool, not antiviral
Ascaris study [3]Parasite vesicle releaseInhibited release, IC50 64 nM

The Ascaris work shows ivermectin does hit a specific target in a worm, blocking vesicle release at a measured concentration [3]. That is parasite biology, not flu. Whether the drug reaches flu-relevant concentrations in human airway cells, and whether it inhibits the virus there, is not in these records.

My call: the evidence here does not show ivermectin inhibits influenza, and the only human antiviral data point runs against it. Confidence: low, because the retrieval simply does not contain an influenza study.

Keep digging

Sources used 3

  1. Old drug, new tricks: the utility of metformin in infection and vaccination responses to influenza and SARS-CoV-2 in older adults Frontiers in Aging (2023) narrative review Strong

    This narrative review concludes that metformin, an FDA-approved geroscience candidate, may improve influenza and SARS-CoV-2 infection outcomes and vaccination responses in older adults by targeting aging hallmarks and immune dysregulation.

    DOI: 10.3389/fragi.2023.1272336
  2. Rhythmic Nuclear Import Mediated by Importins Regulates the Neurospora Circadian Clock Thin

    Circadian timing in Neurospora crassa is controlled by circadian-regulated, Importin α–mediated nuclear import of FRQ and WC-1, with distinct Importin βs contributing via additional cargoes and PP-4 interaction, revealing nuclear import as a dynamic, rate-limiting mechanism shap…

    DOI: 10.64898/2026.01.12.699091
  3. Inhibition of release of intestinal extracellular vesicles in Ascaris suum and immune modulation by the anthelmintic ivermectin primary study Strong

    Intestinal extracellular vesicles from Ascaris suum carry immune- and digestion-associated proteins; ivermectin inhibits their release (IC50 64 nM) and alters their putative immune-related cargo.

    DOI: 10.64898/2026.08.25.745816

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →